Anaergia Reports 30% Revenue Growth and Expands Revenue Backlog¹ to $303 million in Third Quarter
The asset disposals generated a C$21.9 million gain and reduced project-level debt by US$20 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Sale of Charlotte facility and
All financial results are reported in Canadian dollars unless otherwise stated.
Third Quarter 2026 Highlights
-
Revenue increased
30.3% to in the third quarter, compared with$66.9 million in the third quarter of 2025 (“Q3 2025”)$51.4 million -
Revenue Backlog1 reached
, up$303.1 million 10.3% from June 30, 2026, and18.2% from December 31, 2025, as new awards exceeded revenue recognized during the quarter -
New contract awards of approximately
were secured across$86 million Europe ,North America andAustralia , underscoring broad-based commercial momentum -
Adjusted EBITDA1 increased to
from$3.1 million and remained positive for a fifth consecutive quarter$2.6 million -
Gross profit increased
11.0% to in the third quarter, compared with$16.4 million in Q3 2025$14.8 million -
Net Income turned positive to
, compared with a net loss of$19.5 million in Q3 2025$0.5 million -
Recognized a
gain and reduced debt by$21.9 million US on the divestiture of its Charlotte Bioenergy Facility (“CBF”) and the Company’s interests in the Rhode Island Bioenergy Facility HoldCo, LLC (“RIBF”), at the end of Q3 2026. This transaction advances Anaergia’s strategy to concentrate its portfolio around profitable growth opportunities and eliminate the negative earnings associated with non-core assets, as CBF has not been operating and RIBF has been operating below its expected utilization rate$20 million -
For the first nine months of 2026, as compared to the same period in the prior year, revenue increased
71.5% to , Adjusted EBITDA1 improved to$186.0 million from a$6.1 million loss, and net income improved to$3.6 million from a$13.1 million loss$15.8 million
Management Commentary
"In the third quarter we continued to demonstrate Anaergia's improving financial and commercial profile. Revenue increased significantly, Adjusted EBITDA1 was positive for a fifth consecutive quarter, and our Revenue Backlog1 expanded to approximately
"We also took decisive steps to strengthen the quality of our portfolio and balance sheet. The divestiture of CBF and our interest in RIBF generated a
Strengthening Financial Performance and Commercial Momentum
Anaergia's Q3 2026 results reflect higher capital sales project execution in
Management remains focused on converting Revenue Backlog1 into revenue with disciplined project execution, improving operating leverage and selectively pursuing opportunities that meet the Company's return and risk criteria. The disposal of underperforming non-core assets reduces portfolio complexity and allows management to concentrate resources on opportunities with stronger earnings potential.
Third Quarter 2026 Financial Results
Revenue for Q3 2026 was
Gross profit for Q3 2026 was
Net Income turned positive to
For the nine months ended September 30, 2026, revenue increased
Three months ended: |
|
30-Sep-26 |
30-Sep-25 |
% Change |
||
(In millions of Canadian dollars, except %) |
|
|
|
|
||
Revenue |
|
66.9 |
51.4 |
|
||
Gross profit |
|
16.4 |
14.8 |
|
||
Gross profit % |
|
|
|
|
||
Income (loss) from operations |
|
0.5 |
0.6 |
- |
||
Net Income (Loss) |
|
19.5 |
(0.5) |
4, |
||
Adjusted EBITDA1 |
|
3.1 |
2.6 |
|
||
|
|
|
||||
Nine months ended: |
|
30-Sep-26 |
30-Sep-25 |
% Change |
||
(In millions of Canadian dollars, except %) |
|
|
|
|
||
Revenue |
|
186.0 |
108.5 |
|
||
Gross profit |
|
43.6 |
30.7 |
|
||
Gross profit % |
|
|
|
|
||
Income (loss) from operations |
|
(1.9) |
(9.2) |
|
||
Net Income (Loss) |
|
13.1 |
(15.8) |
|
||
Adjusted EBITDA1 |
|
6.1 |
(3.6) |
|
Statement of |
|
|
||
Financial Position |
30-Sep-26 |
31-Dec-25 |
||
(In millions of Canadian dollars) |
|
|
||
Total Assets |
212.5 |
237.9 |
||
Total Liabilities |
171.0 |
182.4 |
||
Equity |
41.5 |
55.5 |
_________________________ |
1 “EBITDA,” “Adjusted EBITDA” and “Revenue Backlog” are non-GAAP measures. See “Non-GAAP Measures.” |
For a more detailed discussion of Anaergia’s results for Q3 2026, please see the Company’s financial statements for Q3 2026 and related MD&A, which are available at https://www.anaergia.com/investor-relations and on the Company’s SEDAR+ page at www.sedarplus.ca.
Non-GAAP Measures
This press release makes reference to certain non-GAAP measures. These non-GAAP measures are not recognized measures under IFRS® Accounting Standards as issued by the International Accounting Standards Board (“IASB”) (“IFRS Accounting Standards”) and do not have a standardized meaning prescribed by IFRS Accounting Standards and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP measures are provided as additional information to complement IFRS Accounting Standards measures by providing further understanding of our results of operations from management’s perspective. Accordingly, these non-GAAP measures should not be considered in isolation or as a substitute for analysis of our financial information reported under IFRS Accounting Standards. We use non-GAAP measures, including “Adjusted EBITDA”, “EBITDA”, and “Revenue Backlog” to provide investors with supplemental measures. Management also uses non-GAAP measures internally in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess our ability to meet our future debt service, capital expenditure and working capital requirements. Management believes these non-GAAP measures are important supplemental measures of operating performance because they eliminate items that have less bearing on operating performance and highlight trends in the core business that may not otherwise be apparent when relying solely on IFRS Accounting Standards financial measures. Management believes such measures are useful as they allow for assessment of our operating performance and financial condition on a basis that is more consistent and comparable between reporting periods. We also believe that securities analysts, investors and other interested parties frequently use non-GAAP measures in the evaluation of issuers.
Definitions of non-GAAP measures and industry metrics used in this press release are provided below.
“Adjusted EBITDA” is defined as net income or loss before interest expenses, taxes and depreciation and amortization adjusted for our normalized proportionate interest in our Build-Own-Operate assets and one-time or non-recurring items, stock-based compensation expense, asset impairment charges and write downs, losses related to equity-accounted investees, significant one-time provisions, foreign exchange gains or losses, restructuring and severance costs, Enterprise Resource Planning customization and configuration costs, litigation and other claims settlements, gains and losses resulting from changes in certain balance sheet valuations (such as derivatives and warrants) and acquisition costs.
“EBITDA” is defined as net income or loss before interest expenses, taxes and depreciation and amortization.
“Revenue Backlog” is defined as the balance of unrecognized, undiscounted, consolidated revenues from signed contracts in our Capital Sales and operation and maintenance services (“O&M Services”) segments. For our Capital Sales contracts, we have modeled only projects that have been contracted. For our O&M Services segment, while most of our in-hand contracts are 5-15 years in tenure, we have conservatively modeled for only 3 years of contracted revenue.
See “Reconciliation of Non-GAAP Measures” below for a reconciliation of EBITDA and Adjusted EBITDA to their most directly comparable measures calculated in accordance with GAAP.
Conference Call and Webcast Details
A conference call to review the Company’s financial results will take place at 9:30 a.m. (EST) on Thursday, November 12, 2026. It will be hosted by management of Anaergia. An accompanying slide presentation will be posted to the Investor Relations section of the Company’s website shortly before the call.
To listen to the webcast live: https://events.q4inc.com/attendee/678994211
The webcast will be archived and available in the Investor Relations section of our website following the call.
About Anaergia
Anaergia is a global technology and project delivery company focused on converting organic waste into renewable natural gas, fertilizer, and clean water. Through its proprietary technologies, engineering expertise, and integrated portfolio of solutions, Anaergia helps municipalities, utilities, industrial customers, and project owners reduce waste management costs, recover valuable resources, and lower greenhouse gas emissions. The Company offers comprehensive end-to-end capabilities spanning solid waste processing, wastewater treatment, organics recovery, anaerobic digestion, biomethane production, facility construction, and long-term operations.
For further information please see: www.anaergia.com
Forward-Looking Statements
This press release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information may relate to future plans, expectations and intentions, results, levels of activity, performance, goals or achievements, other future events or developments and may include, without limitation, information regarding our financial position, business strategy, growth strategy, budgets, operations, financial results, taxes, plans and objectives. Particularly, information regarding our future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information. In some cases, forward-looking information can be identified by the use of forward-looking terminology such as “may”, “will”, “would”, “should”, “could”, “expects”, “plans”, “intends”, “estimate”, “believes”, “likely”, “potential”, “continue”, or “future” or the negative or other variations of these words or other comparable words or phrases. In addition, any statements that refer to expectations, intentions, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not facts but instead represent management’s expectations, estimates and projections regarding future events or circumstances. Forward-looking statements in this press release include, among other things, statements relating to financial condition and results of operations; the Company’s strategy and execution of its strategy; the Company’s business model, including our focus on revenue growth and operating discipline, and its impact on our financial performance; the Company’s capabilities to deliver integrated end-to-end solutions across organic waste processing, anaerobic digestion, biomethane production, wastewater treatment, and resource recovery; and statements regarding the Company’s Revenue Backlog and potential future sales.
Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that we considered appropriate and reasonable as of the date such statements were made. It is also subject to known and unknown risks, uncertainties, assumptions and other factors that may cause our actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the risk factors described in the Company’s annual information form and management’s discussion and analysis for the year ended December 31, 2025. Certain assumptions in respect of our ability to execute on our expansion plans; our ability to obtain or maintain existing financing on acceptable terms; and our ability to realize the anticipated benefits of such are material factors underlying forward looking information and management’s expectations. The purpose of the forward-looking statements in this press release is to provide the reader with a description of management’s current expectations regarding the Company’s financial performance and may not be appropriate for other purposes. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information, which speaks only to opinions, estimates and assumptions as of the date made. Furthermore, unless otherwise stated, the forward-looking statements contained in this press release are made as of the date of this press release, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.
Reconciliation of Non-GAAP Measures
Three months ended: |
30-Sep-26 |
30-Sep-25 |
||
(In thousands of Canadian dollars) |
|
|
||
Net Income (Loss) |
19,548 |
(451) |
||
Finance costs, net |
1,516 |
1,264 |
||
Depreciation and amortization |
2,116 |
1,409 |
||
Income tax expense |
715 |
516 |
||
EBITDA1 |
23,895 |
2,738 |
||
Share-based compensation expense |
531 |
554 |
||
Other (gains) losses, net |
(423) |
(330) |
||
Gain on disposal of CBF and RIBF |
(21,923) |
- |
||
Loss on remeasurement of investment |
2,215 |
- |
||
Foreign exchange loss |
(1,175) |
(399) |
||
Adjusted EBITDA1 |
3,120 |
2,563 |
Nine months ended: |
30-Sep-26 |
30-Sep-25 |
||
(In thousands of Canadian dollars) |
|
|
||
Net Income (Loss) |
13,097 |
(15,836) |
||
Finance costs, net |
4,041 |
3,546 |
||
Depreciation and amortization |
6,107 |
4,283 |
||
Income tax expense (recovery) |
2,696 |
688 |
||
EBITDA1 |
25,941 |
(7,319) |
||
Share-based compensation expense |
1,856 |
1,319 |
||
Other (gains) losses, net |
(826) |
881 |
||
Gain on disposal of CBF and RIBF |
(21,923) |
- |
||
Loss on remeasurement of investment |
2,215 |
- |
||
Foreign exchange gains (losses) |
(1,154) |
1,518 |
||
Adjusted EBITDA1 |
6,109 |
(3,601) |
_________________________ |
1 “EBITDA,” “Adjusted EBITDA” and “Revenue Backlog” are non-GAAP measures. See “Non-GAAP Measures.” |
View source version on businesswire.com: https://www.businesswire.com/news/home/20261111147148/en/
For media and/or investor relations please contact: IR@Anaergia.com
Source: Anaergia Inc.